Cure8 research brief
People with suspected IBD or clinicians working where fecal calprotectin testing is unavailable may be interested because the study explores simpler endoscopic signs and routine blood indices as an alternative way to predict ulcerative colitis.
Gastroenterologists and endoscopists, clinicians in resource-limited settings, researchers developing diagnostic models for IBD, and patients undergoing evaluation for suspected UC.
The study suggests that in settings where fecal calprotectin is not available, certain simplified endoscopic features—alone or combined with routine blood-count–derived indices—may help distinguish UC from other causes of inflammation.
The combined model had an optimism-corrected AUC ~0.73 and a high negative predictive value at the reported cutoff, but overall discrimination was moderate and improvement from blood indices was modest. Interpretation: This is a retrospective diagnostic-modeling study (abstract-level summary).
The findings point to possible clinical tools for centers lacking FC testing, but do not establish a validated clinical rule for widespread use. Further external validation and prospective testing would be needed before changing practice.
This is an abstract-level summary of a retrospective multicenter study; the models showed only moderate accuracy and were internally validated but require external prospective validation. Fecal calprotectin was rarely recorded in the dataset, limiting comparison to that test.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Non-invasive biomarkers that reflect mucosal inflammation and systemic disease activity could help reduce reliance on frequent endoscopy and guide monitoring for people with Crohn’s disease or ulcerative colitis.
A wearable sensor that reliably measures inflammation markers (CRP and calprotectin) from sweat could make inflammation monitoring less invasive and more frequent for people with IBD, potentially helping detect flares...
Knowing which symptoms and non-invasive biomarkers most strongly associate with UC can help patients and clinicians decide who should be prioritized for diagnostic endoscopy and for monitoring disease activity.
